Dr. Matthew H. Carabasi MD Medical Oncologist
Dr. Matthew Carabasi is a medical oncologist in Philadelphia, Pennsylvania. He is affiliated with multiple hospitals in the area, including Lankenau Medical Center and Thomas Jefferson University Hospital. He received his medical degree from Jefferson Medical College and has been in practice for 30 years. Dr. Carabasi accepts several types of health insurance, listed below. He is one of 15 doctors at Lankenau Medical Center and one of 19 at Thomas Jefferson University Hospital who specialize in Medical Oncology.
Are you Dr. Matthew Carabasi? Claim your profile to make edits or add details.Edit Profile
Specialty & Clinical Interests
Medical Oncologist: Hematologic
Clinical Interests: Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease
Education & Medical Training
Drexel University/Hahnemann University Hospital
Residency, Internal Medicine, 1980 - 1983
Memorial Sloan-Kettering Cancer Center
Fellowship, Medical Oncology, 1985 - 1989
Jefferson Medical College
Class of 1980
Certifications & Licensure
American Board of Internal Medicine
Certified 31 years in Internal Medicine
American Board of Internal Medicine
Certified 27 years in Medical Oncology
PA State Medical License
Awards, Honors & Recognition
Meaningful Use Stage 1 Certification,
Centers for Medicare & Medicaid Services
Publications & Presentations
Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?
Horan, J.T., Logan, B.R., Agovi-Johnson, M., Lazarus, H.M., Bacigalupo, A.A., Ballen, K.K., Bredeson, C.N., Carabasi, M.H., Gupta, V., Hale, G.A., Khoury, H.J., Juckett, M.B., Litzow, M.R., Martino, R., McCarthy, P.L., Smith, F.O., Rizzo, J.D., Pasquini
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.
Lee, S.J., Kukreja, M., Wang, T., Giralt, S.A., Szer, J., Arora, M., Woolfrey, A.E., Cervantes, F., Champlin, R.E., Gale, R.P., Halter, J., Keating, A., Marks, D.I., McCarthy, P.L., Olavarria, E., Stadtmauer, E.A., Abecasis, M., Gupta, V., Khoury, H.J., G
A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies.
Bartlett, N.L., Younes, A., Carabasi, M.H., Forero, A., Rosenblatt, J.D., Leonard, J.P., Bernstein, S.H., Bociek, R.G., Lorenz, J.M., Hart, B.W., Barton, J.
- Aetna Choice POS II
- Aetna HMO
- AmeriHealth Direct POS
- Amerihealth HMO
- AmeriHealth PPO
- BCBS Blue Card PPO
- BCBS California PPO
- CIGNA HMO
- CIGNA Open Access
- CIGNA PPO
- Coventry Carelink Health Plans PPO
- First Health PPO
- Great West PPO
- Health Net California Large Group PPO
- HealthAmerica HealthAssurance PPO
- Horizon BCBS Direct Access
- Horizon BCBS HMO
- Horizon BCBS POS
- Horizon BCBS PPO
- Humana ChoiceCare Network PPO
- IBC Keystone HMO / POS
- IBC Personal Choice PPO
- Multiplan PHCS PPO
- Multiplan PPO
- QualCare HMO
- QualCare PPO
- United Healthcare - Direct Choice Plus POS
- United Healthcare - Direct Options PPO
Help Us Keep the "U.S. News Doctor Finder" Current
If you are aware of information on this pagethat is out of date or incorrect, please let us know.
*Required Field | Your email will not be used for marketing.
Your Message Has Been Submitted
As part of our research on the correction you submitted, you may be contacted at the email address provided.
Sorry, Your Message Could Not Be Submitted
Please try again later, or E-mail your message to email@example.com and include the Web address (URL) of the page that contains incorrect information.
111 S 11th St
Philadelphia, PA 19107
Phone: (215) 955-8874
Fax: (215) 955-2340